Literature DB >> 29422428

Clinical implementation of contrast-enhanced four-dimensional dual-energy computed tomography for target delineation of pancreatic cancer.

Shingo Ohira1, Kentaro Wada2, Takero Hirata2, Naoyuki Kanayama2, Toshiki Ikawa2, Tsukasa Karino2, Yuya Nitta2, Masaru Isono2, Yoshihiro Ueda2, Masayoshi Miyazaki2, Masahiko Koizumi3, Teruki Teshima4.   

Abstract

BACKGROUND AND
PURPOSE: The accurate delineation of pancreatic tumor with respiratory motion is challenging. This study demonstrates the application of contrast-enhanced four-dimensional dual-energy computed tomography (CE-4D-DECT) for tumor delineation and assesses the objective and subjective image quality.
MATERIAL AND METHODS: Twelve patients underwent CE-4D-DECT, and quantitative spectral analysis was performed on the resulting virtual monochromatic images (VMI) to determine the optimal VMI (O-VMI) with the highest contrast-to-noise ratio (CNR). The objective value of the CNR between pancreatic parenchyma and tumor, and the subjective measurement with five-point scale were compared between O-VMI, standard VMI (S-VMI, 77 keV) and single energy CT (SECT, 120 kVp).
RESULTS: The CNR was the highest in the VMI at 60 keV, and the corresponding CNR in the O-VMI (3.4) was significantly higher (p < 0.05) than that in the S-VMI (2.4) and the SECT (2.7). The overall mean subjective measurements among 4 radiation oncologists were higher for the O-VMI over the S-VMI and SECT with respect to overall image quality (4.0, 3.3 and 3.7, respectively), tumor enhancement (3.4, 2.6 and 3.2, respectively), and vessel delineation (4.2, 3.6 and 4.2, respectively).
CONCLUSIONS: The O-VMI derived from the CE-4D-DECT demonstrated its superiority over the S-VMI and SECT in depicting pancreatic tumor.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  4DCT; Contrast enhanced; Dual energy; Pancreatic cancer

Mesh:

Year:  2018        PMID: 29422428     DOI: 10.1016/j.radonc.2018.01.012

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

Review 1.  Status and innovations in pre-treatment CT imaging for proton therapy.

Authors:  Patrick Wohlfahrt; Christian Richter
Journal:  Br J Radiol       Date:  2019-11-11       Impact factor: 3.039

2.  Dual-energy computed tomography for evaluation of breast cancer: value of virtual monoenergetic images reconstructed with a noise-reduced monoenergetic reconstruction algorithm.

Authors:  Kanako Okada; Megumi Matsuda; Takaharu Tsuda; Teruhito Kido; Akihiro Murata; Hikaru Nishiyama; Kanako Nishiyama; Haruna Yamasawa; Yoshiaki Kamei; Mie Kurata; Mana Fukushima; Riko Kitazawa; Teruhito Mochizuki
Journal:  Jpn J Radiol       Date:  2019-11-04       Impact factor: 2.374

3.  Improvement of image quality and assessment of respiratory motion for hepatocellular carcinoma with portal vein tumor thrombosis using contrast-enhanced four-dimensional dual-energy computed tomography.

Authors:  Shingo Ohira; Naoyuki Kanayama; Kentaro Wada; Toshiki Ikawa; Takero Hirata; Noriko Kishi; Tsukasa Karino; Hayate Washio; Yoshihiro Ueda; Masayoshi Miyazaki; Masahiko Koizumi; Teruki Teshima
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

4.  Determination of optimal virtual monochromatic energy level for target delineation of brain metastases in radiosurgery using dual-energy CT.

Authors:  Tsukasa Karino; Shingo Ohira; Naoyuki Kanayama; Kentaro Wada; Toshiki Ikawa; Yuya Nitta; Hayate Washio; Masayoshi Miyazaki; Teruki Teshima
Journal:  Br J Radiol       Date:  2019-12-20       Impact factor: 3.039

5.  Dosimetric effect of rotational setup errors in stereotactic radiosurgery with HyperArc for single and multiple brain metastases.

Authors:  Tomohiro Sagawa; Shingo Ohira; Yoshihiro Ueda; Yuichi Akino; Hirokazu Mizuno; Masao Matsumoto; Masayoshi Miyazaki; Masahiko Koizumi; Teruki Teshima
Journal:  J Appl Clin Med Phys       Date:  2019-09-11       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.